Related references
Note: Only part of the references are listed.The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent
Chen Li et al.
CANCER BIOLOGY & THERAPY (2015)
Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma
Bing Zheng et al.
CANCER LETTERS (2015)
C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling
Min-Bin Chen et al.
CARCINOGENESIS (2015)
The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2
Bo Chen et al.
DNA AND CELL BIOLOGY (2015)
COLORECTAL CANCER IN 2014 Progress in defining first-line and maintenance therapies
Joleen M. Hubbard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Bufotalin-induced apoptosis in osteoblastoma cells is associated with endoplasmic reticulum stress activation
Yun-Rong Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer
Min-Bin Chen et al.
CELLULAR SIGNALLING (2014)
COLORECTAL CANCER IN 2013 Towards improved drugs, combinations and patient selection
Hans-Joachim Schmoll et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
COLORECTAL CANCER Adjuvant chemotherapy for rectal cancer-an unresolved issue
Manisha Palta et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Autophagy-a key player in cellular and body metabolism
Kook Hwan Kim et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Understanding the routes of metastasis in colorectal cancer
Isobel Leake
Nature Reviews Gastroenterology & Hepatology (2014)
Self-consumption: the interplay of autophagy and apoptosis
Guillermo Marino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways
Ashok Kumar Pandurangan
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
The dual mTORC1 and mTORC2 inhibitor AZD8055 inhibits head and neck squamous cell carcinoma cell growth in vivo and in vitro
Qiang Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells
Min-Bin Chen et al.
CELLULAR SIGNALLING (2013)
Colorectal cancer screening-optimizing current strategies and new directions
Ernst J. Kuipers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Dectin-1-triggered Recruitment of Light Chain 3 Protein to Phagosomes Facilitates Major Histocompatibility Complex Class II Presentation of Fungal-derived Antigens
Jun Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Autophagy modulation as a potential therapeutic target for diverse diseases
David C. Rubinsztein et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Activation of AMP-Activated Protein Kinase is Involved in Vincristine-Induced Cell Apoptosis in B16 Melanoma Cell
Min-Bin Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
Eduardo Vilar et al.
MOLECULAR CANCER THERAPEUTICS (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model
Jie Li et al.
EUROPEAN JOURNAL OF CANCER (2010)
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer
Anna Isinger Ekstrand et al.
FAMILIAL CANCER (2010)
mToR signaling and drug development in cancer
Janet Dancey
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Molecular Targeted Therapy in Prevalent Tumors: Learning from the Past and Future Perspectives
Otto Metzger-Filho et al.
CURRENT CLINICAL PHARMACOLOGY (2010)
mTOR Signaling Pathway Is a Target for the Treatment of Colorectal Cancer
Yan-Jie Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin
Ker Yu et al.
CANCER RESEARCH (2009)
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Chang Hwa Jung et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
FoxO3 controls autophagy in skeletal muscle in vivo
Cristina Mammucari et al.
CELL METABOLISM (2007)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
Clinical development of gene therapy for colorectal cancer
D Kerr
NATURE REVIEWS CANCER (2003)
Share Paper
